Finance

Lists
Why is AUPH up 2,04%?
Dive Deeper
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
16,01 USD
+2,04%
(+0,32) 1D
16,01 USD
0,00% (0,00)
After hours
Closed: 7-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
15,56 USD
High
16,16 USD
Low
15,50 USD
Mkt. cap
2,13 млд
Avg. vol.
807,66 миң
Volume
656,13 миң
P/E ratio
6,99
52-wk high
19,25 USD
52-wk low
10,92 USD
EPS
2,29 USD
Beta
1,60
Shares outstanding
133,05 млн
No. of employees
128
Open
15,56 USD
High
16,16 USD
Low
15,50 USD
Mkt. cap
2,13 млд
Avg. vol.
807,66 миң
Volume
656,13 миң
P/E ratio
6,99
52-wk high
19,25 USD
52-wk low
10,92 USD
EPS
2,29 USD
Beta
1,60
Shares outstanding
133,05 млн
No. of employees
128
News stories
From web sources and news partners
About Aurinia Pharmaceuticals Inc
CEO-
Employees128
Founded2012
HeadquartersЭдмонтон, Элберта, Канада
Sector-
Websiteauriniapharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current 16,01 USD
21,00 USD (+31,17%)
Average
18,00 USD (+12,43%)
Lowest
16,00 USD (-0,06%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Martin PhD
Bloom Burton
Buy
Upgraded
21,00 USD
+31,2%
08/20/2026
Stacy Ku
TD Cowen
Buy
Maintained
17,00 USD
+6,2%
08/19/2026
Douglas Miehm
RBC Capital
Hold
Maintained
16,00 USD
-0,1%
08/07/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
17,00 USD
+6,2%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
73,47 млн
77,11 млн
77,70 млн
83,22 млн
Cost of goods sold
8,50 млн
40,55 млн
13,98 млн
18,30 млн
Cost of revenue
8,50 млн
40,55 млн
13,98 млн
18,30 млн
Research and development expenses
8,11 млн
-20,86 млн
-
1,31 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,18 млн
29,26 млн
22,03 млн
23,51 млн
Operating expense
35,22 млн
-6,37 млн
22,31 млн
18,58 млн
Total operating expenses
43,72 млн
34,18 млн
36,28 млн
36,88 млн
Operating income
29,74 млн
42,94 млн
41,42 млн
46,34 млн
Other non operating income
-
-
-
-
EBT including unusual items
31,96 млн
35,69 млн
43,92 млн
48,79 млн
EBT excluding unusual items
31,96 млн
35,69 млн
43,92 млн
48,79 млн
Income tax expense
411,00 миң
-175,10 млн
9,57 млн
11,37 млн
Effective tax rate
1,29%
-490,62%
21,79%
23,31%
Other operating expenses
929,00 миң
-14,77 млн
279,00 миң
-6,23 млн
Net income
31,55 млн
210,79 млн
34,36 млн
37,41 млн
Net profit margin
42,95%
273,35%
44,21%
44,96%
Earnings per share
0,23
1,53
0,25
0,28
Interest and investment income
3,32 млн
3,50 млн
3,52 млн
3,39 млн
Interest expense
-1,10 млн
-1,05 млн
-1,01 млн
-948,00 миң
Net interest expenses
2,22 млн
2,45 млн
2,50 млн
2,44 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
34,61 млн
47,80 млн
46,24 млн
51,18 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору